BlueRock Therapeutics has dosed the first patient in its pivotal phase 3 trial of bemdaneprocel, an investigational cell ...
Johnson & Johnson has announced a positive opinion from the CHMP recommending expanded marketing authorisation for TREMFYA ...
Three new studies have launched in Manchester to evaluate the effectiveness of vaccines for severe acute respiratory ...
Xeltis has announced successful results from its aXess EU phase 3 trial, confirming the potential of its restorative vascular ...
Tezspire (tezepelumab) has received a positive opinion from the CHMP for the treatment of chronic rhinosinusitis with nasal ...
Acella Pharmaceuticals and Neuvosyn Laboratories have announced positive topline results from a phase 2 clinical trial of ...
As an occupation at the very epicentre of healthcare, the nurse is a constant and iconic presence. In this edition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback